Shanghai OPM Biosciences Co., Ltd.

¥63.06As of Sun 8 Nov 2026, 12:00 UTC
SSE:688293Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (6.80%)
Div yield 0.68%
ROE 1.41%
Biotechnology
Beta (5Y) 0.70
PE TTM 204.1
TSR TTM 2.74%
Mkt cap ¥8.967B
ROIC 4.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥76
20.52%
(95.81%)
Hold 6|7|12|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.50
1.53
1.49
1.53
21.08%
29.61%
13.50%
10.47%
Revenue¥M
543.0
566.5
564.4
596.1
3.02%
4.67%
0.39%
8.94%
Peers (US$1.344B)
Cap (US$)
PE
1.316B
122.1x
1.343B
—
Capital
TTM
5Y
10Y
Leveragex
2.489
—
—
EBIT/Intx
1.031
0.191
0.218
Own earn%
22.67
17.93
7.45
Sh yield%
50.54
32.87
29.63
Owners
Insiders/Inst%
0.48
79.78
Short interest%
0.60
SBC / revenue%
2.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–12
$1 testx
−0.2
Incr. ROIC%
8